Mark Froimson
CIK 1709050 · last filed 2026-03-19
Mark Froimson is a corporate insider who has filed 16 SEC Form 4 insider transactions across 1 company since 2017. The most recent filing shows the insider sold $10.9K of PCRX on Mar 19, 2026. Across all open-market trades the lifetime net is −$103.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $462.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$462.9K
1
16
-$103.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCRX | Director | 20,136 | $22.99 | $462.9K | -$103.4K | 16 | 2026-03-19 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-19 | PCRX | Sell (S) | −500 | -$10.9K | EDGAR |
| 2025-06-13 | PCRX | Grant (A) | +6,163 | $0 | EDGAR |
| 2024-08-12 | PCRX | Buy (P) | +1,400 | $16.2K | EDGAR |
| 2024-06-13 | PCRX | Grant (A) | +5,230 | $0 | EDGAR |
| 2023-06-16 | PCRX | Grant (A) | +1,775 | $0 | EDGAR |
| 2022-06-08 | PCRX | Grant (A) | +1,160 | $0 | EDGAR |
| 2022-05-11 | PCRX | Sell (S) | −1,000 | -$59.4K | EDGAR |
| 2021-12-20 | PCRX | Gift (G) | −400 | $0 | EDGAR |
| 2021-06-11 | PCRX | Grant (A) | +1,066 | $0 | EDGAR |
| 2021-03-17 | PCRX | Sell (S) | −734 | -$53.0K | EDGAR |